PACS Group (NYSE:PACS) Director Mark Hancock Sells 186,696 Shares of Stock

Posted by Andrew Walz on Nov 4th, 2026

PACS Group, Inc. (NYSE:PACS – Get Free Report) Director Mark Hancock sold 186,696 shares of the stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $50.45, for a total value of $9,418,813.20. Following the completion of the transaction, the director directly owned 53,318,884 shares of the company’s stock, valued at approximately $2,689,937,697.80. The trade was a 0.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Hancock also recently made the following trade(s):

On Thursday, October 29th, Mark Hancock sold 4,280 shares of PACS Group stock. The shares were sold at an average price of $50.02, for a total transaction of $214,085.60.
On Wednesday, October 28th, Mark Hancock sold 9,024 shares of PACS Group stock. The stock was sold at an average price of $50.10, for a total transaction of $452,102.40.
On Tuesday, September 15th, Mark Hancock sold 155,682 shares of PACS Group stock. The shares were sold at an average price of $42.47, for a total transaction of $6,611,814.54.
On Monday, September 14th, Mark Hancock sold 144,318 shares of PACS Group stock. The shares were sold at an average price of $44.57, for a total transaction of $6,432,253.26.

PACS Group Price Performance

PACS Group stock traded up $3.95 during trading hours on Wednesday, hitting $50.63. 1,790,293 shares of the company traded hands, compared to its average volume of 895,995. PACS Group, Inc. has a 1-year low of $10.31 and a 1-year high of $51.68. The firm has a market cap of $8.01 billion, a P/E ratio of 29.44, a P/E/G ratio of 1.42 and a beta of -0.14. The firm’s 50-day simple moving average is $44.29 and its two-hundred day simple moving average is $39.85. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21.

PACS Group (NYSE:PACS – Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.46 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. As a group, analysts forecast that PACS Group, Inc. will post 2.13 earnings per share for the current fiscal year.

Trending Headlines about PACS Group

Here are the key news stories impacting PACS Group this week:

Positive Sentiment: PACS reported third-quarter 2026 earnings of $0.63 per share, above estimates of $0.56–$0.58 and up from $0.32 a year earlier. Revenue of $1.50 billion also topped forecasts of $1.46 billion, supporting the positive market reaction. PACS Group, Inc. Reports Third Quarter 2026 Results PACS Group Q3 Earnings and Revenues Beat Estimates
Negative Sentiment: CEO Jason Murray, director Mark Hancock, and chief accounting officer Michelle Lewis reported share sales. The sales could raise a modest concern about insider sentiment, but they were conducted under Rule 10b5-1 plans; Murray and Hancock continued to hold roughly 54 million shares each. CEO Form 4 filing Director Form 4 filing Chief accounting officer Form 4 filing

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on PACS shares. Zacks Research cut PACS Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 9th. Weiss Ratings raised PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Royal Bank Of Canada lifted their target price on PACS Group from $52.00 to $57.00 and gave the stock an “outperform” rating in a report on Thursday, August 6th. Oppenheimer boosted their price target on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Finally, UBS Group upped their price target on shares of PACS Group from $57.00 to $60.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Five research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $58.80.

Get Our Latest Stock Analysis on PACS Group

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Nisa Investment Advisors LLC lifted its position in shares of PACS Group by 11.0% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,327 shares of the company’s stock valued at $97,000 after acquiring an additional 230 shares during the last quarter. Financial Management Professionals Inc. boosted its stake in shares of PACS Group by 54.9% during the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after acquiring an additional 235 shares in the last quarter. Smith Group Asset Management LLC boosted its stake in shares of PACS Group by 1.3% during the 3rd quarter. Smith Group Asset Management LLC now owns 24,680 shares of the company’s stock worth $1,025,000 after acquiring an additional 320 shares in the last quarter. Jacobsen Capital Management grew its holdings in shares of PACS Group by 3.4% in the 3rd quarter. Jacobsen Capital Management now owns 17,837 shares of the company’s stock worth $741,000 after acquiring an additional 579 shares during the last quarter. Finally, Toth Financial Advisory Corp grew its holdings in shares of PACS Group by 87.5% in the 3rd quarter. Toth Financial Advisory Corp now owns 1,500 shares of the company’s stock worth $62,000 after acquiring an additional 700 shares during the last quarter.

About PACS Group

(Get Free Report)

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.